Leo has always said that he wants CTIX to follow the royalty model -- we do the research, then license it out to big pharma. He said one time (approximate quote) "I have no desire to be CEO of a pharmaceutical manufacturing company." And from the shareholders' standpoint, it is MUCH less risky to be licensing stuff out and getting royalties, than it is to have the company owning factories, having a sales force, and then if sales are bad, seeing wild fluctuations in share value. If sales are bad, we just get lower royalties but we don't have any capital write-offs, or have people whose salaries still have to be paid.

I applaud the business model Leo says he wants for us.